Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. To compare global differences in ease of access to biologics. In April 2021, national prescription criteria for omalizumab, mepol...

Celý popis

Podrobná bibliografia

Vydané v:	The journal of allergy and clinical immunology in practice (Cambridge, MA) Ročník 10; číslo 5; s. 1202
Hlavní autori:	Porsbjerg, Celeste M, Menzies-Gow, Andrew N, Tran, Trung N, Murray, Ruth B, Unni, Bindhu, Audrey Ang, Shi Ling, Alacqua, Marianna, Al-Ahmad, Mona, Al-Lehebi, Riyad, Altraja, Alan, Belevskiy, Andrey S, Björnsdóttir, Unnur S, Bourdin, Arnaud, Busby, John, Canonica, G Walter, Christoff, George C, Cosio, Borja G, Costello, Richard W, FitzGerald, J Mark, Fonseca, João A, Hansen, Susanne, Heaney, Liam G, Heffler, Enrico, Hew, Mark, Iwanaga, Takashi, Jackson, Daniel J, Kocks, Janwillem W H, Kallieri, Maria, Bruce Ko, Hsin-Kuo, Koh, Mariko Siyue, Larenas-Linnemann, Désirée, Lehtimäki, Lauri A, Loukides, Stelios, Lugogo, Njira, Maspero, Jorge, Papaioannou, Andriana I, Perez-de-Llano, Luis, Pitrez, Paulo Márcio, Popov, Todor A, Rasmussen, Linda M, Rhee, Chin Kook, Sadatsafavi, Mohsen, Schmid, Johannes, Siddiqui, Salman, Taillé, Camille, Taube, Christian, Torres-Duque, Carlos A, Ulrik, Charlotte, Upham, John W, Wang, Eileen, Wechsler, Michael E, Bulathsinhala, Lakmini, Carter, Victoria, Chaudhry, Isha, Eleangovan, Neva, Hosseini, Naeimeh, Rowlands, Mari-Anne, Price, David B, van Boven, Job F M
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.05.2022
Predmet:	Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Asthma - epidemiology Biological Products - therapeutic use Biological Therapy Humans Omalizumab - therapeutic use Prescriptions Biologics access Biologics eligibility Severe asthma
ISSN:	2213-2201, 2213-2201
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!